Medical Insurance Premium Assistance Is Now Available!
Co-Pay Relief Program Fund Notices
Would you like to be notified when any new funds open, or when any of our current funds re-open? If so, please sign up using the “Get Notified” link below. As a member of our subscriber community you will receive important news about all of our disease funds, so join today!
This fund is currently closed to new and renewal applications due to lack of sufficient funding. CPR allocates funding to all patient’s that are approved for a grant so that it is available when needed by the patient. Therefore, during the period that a fund is closed to new applications, CPR continues to provide support to all patients in those funds that have an active award. Funds reopen often so please continue to visit our Disease Fund page to check the status of the fund.Fund Type
- Co-pay, Co-insurance & Deductibles
- Office visits and administration charges related to treatment
- Medical Insurance premiums
$15,000 Per Year
- Household Income Requirements 400% or less of Federal Poverty Guideline (FPG) (adjusted for Cost of Living Index (COLI) and number in household)
- Insurance Requirements All Insurance Types
- Patient must reside and receive treatment in the United States.
About Cystic Fibrosis
Cystic fibrosis (CF) is an inherited disease that causes progressive damage to the respiratory system and chronic digestive system problems but can involve multiple organ systems of the body. Mutations in the cystic fibrosis trans-membrane regulator protein (CFTR) impacts the body’s ability to move sodium, chloride and water in and out of cells, leading to unusually thick and sticky mucus in many tissues of the body including the airways, pancreatic ducts, sweat ducts, sinuses and bowels. Cystic fibrosis affects more than 30,000 people in the U.S., although there are approximately 10-12 million carriers of the CFTR mutation in the U.S., the disease affects males and females equally. Other names for this condition include:CF, cystic fibrosis of pancreas, fibrocystic disease of pancreas and mucoviscidosis.